Lyra Therapeutics Inc. Insider Trading

LYRA

Last 12 months

Insiders sold 8K and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Nov 2023.

Net open-market

−8K

0 buys · 2 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Nov 2023

Nov 10, 2023

Get an email when LYRA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jan 6	Jason Cavalier Chief Financial Officer	Sold10b5-1 plan	769	$3.36	3K	0.1%	Form 4
Jan 6	Maria Palasis President & CEO	Sold10b5-1 plan	1,702	$3.36	6K	0.2%	Form 4
Nov 11, 2025 – Nov 13, 2025	Perceptive Advisors LLC Large holder	SoldNo plan 6 parts	45,875	$3.98 average	182K	77%	Form 4
Nov 6, 2025 – Nov 10, 2025	Joseph Edelman Large holder	SoldNo plan 6 parts	70,390	$4.89 average	344K	79%	Form 4
Jul 10, 2025	Maria Palasis President & CEO	Sold10b5-1 plan	1,565	$8.91	14K	0.1%	Form 4
Jul 10, 2025	Jason Cavalier Chief Financial Officer	Sold10b5-1 plan	684	$8.91	6K	0.1%	Form 4

Jan 610b5-1 plan
Jason Cavalier
Chief Financial Officer · sold 769 at $3.36
3K
0.1% of stake
Jan 610b5-1 plan
Maria Palasis
President & CEO · sold 1,702 at $3.36
6K
0.2% of stake
Nov 11, 2025 – Nov 13, 2025No plan
Perceptive Advisors LLC
Large holder · sold 45,875 at avg $3.98
182K
77% of stake
Nov 6, 2025 – Nov 10, 2025No plan
Joseph Edelman
Large holder · sold 70,390 at avg $4.89
344K
79% of stake
Jul 10, 202510b5-1 plan
Maria Palasis
President & CEO · sold 1,565 at $8.91
14K
0.1% of stake
Jul 10, 202510b5-1 plan
Jason Cavalier
Chief Financial Officer · sold 684 at $8.91
6K
0.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LYRA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with LYRA

CompareIntrinsic value

IINNInspira Technologies Oxy B.H.N. Ltd.

$1.01-9.82%10

FOFAFamily Office of America Inc.

$0.78+0.00%16

STSSSkyAI, Inc.

$2.95+0.00%25

PAVMPAVmed Inc.

$1.66-8.79%25

CODXCo-Diagnostics Inc.

$0.36-5.00%10

RDGLVivos Inc.

$0.04-1.64%40

PLSEPulse Biosciences, Inc.

$57.06+9.31%40

HRGNHarvard Apparatus Regenerative Technology Inc.

$2.30+0.00%10

Spot a number that looks wrong? Check it in LYRA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LYRA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.